Archives
-
nor-NOHA Acetate: Designing Metabolic Assays
2026-09-17
Explore how nor-NOHA acetate can dissect arginine partitioning, apoptosis induction in HepG2 cells, and endothelial function restoration. This article adds an assay-design framework linking reversible arginase inhibition to, but carefully distinguishing it from, CD36-driven immune escape in AML.
-
Calpeptin: Practical Calpain Inhibitor Workflows
2026-09-16
Calpeptin combines nanomolar calpain 1 inhibition with a practical workflow for connecting protease activity to fibrosis, inflammation, and cell-death phenotypes. This guide covers dose finding, orthogonal readouts, sample handling, and troubleshooting for pulmonary fibrosis research.
-
5-Azacytidine Workflows for DNA Demethylation
2026-09-16
Build reproducible 5-Azacytidine assays for gene reactivation, leukemia cytotoxicity, and cancer-cell dormancy. This guide connects practical formulation and dosing choices with the AZA–retinoic acid strategy reported for suppressing metastatic outgrowth.
-
Chronic Stress, Mitochondria, and Depression-Like Behavior
2026-09-15
A February 2025 rat study used chronic unpredictable mild stress and intracerebroventricular MnTBAP to connect mitochondrial dysfunction with neuroinflammation and depression-like behavior. Its main contribution is experimental support for mitochondria as a modifiable contributor to stress-related behavioral changes, while route, model validity, and antioxidant specificity limit direct clinical translation.
-
PA-824: Reliable TB Assay Design
2026-09-15
This scenario-driven guide explains how PA-824, SKU A1736, can improve planning and interpretation of Mycobacterium tuberculosis viability and susceptibility experiments. It connects formulation, mechanistic evidence, assay controls, storage, and vendor documentation to more reproducible laboratory decisions.
-
Cisplatin (CDDP) Workflows for Cancer Research
2026-09-14
Build more reproducible Cisplatin workflows for viability, apoptosis, DNA-damage, resistance, and xenograft studies. A recent enzyme-responsive delivery study shows how CDDP assays can be extended from single-agent cytotoxicity to mechanism-guided combination research.
-
Calpeptin Workflows for EV and Fibrosis Research
2026-09-14
Calpeptin connects calpain biology with practical assays for extracellular-vesicle release, pulmonary fibrosis, and inflammatory signaling. This guide translates published EV findings into controlled workflows, normalization strategies, and troubleshooting decisions for reproducible cell-based research.
-
APEX2 Enables TERT Expression in Human Stem Cells
2026-09-13
This preprint identifies APEX2, but not its paralog APEX1, as a contributor to efficient TERT expression and telomerase activity in human embryonic stem cells and a melanoma cell line. Its RNA-seq and chromatin-binding data suggest that APEX2 may connect DNA repair at repetitive elements with regulation of TERT transcription.
-
Filipin III: Membrane Cholesterol Detection
2026-09-12
Filipin III is a polyene macrolide antibiotic used for cholesterol detection in membranes, membrane cholesterol visualization, and membrane-domain studies. Its cholesterol-associated fluorescence quenching and selective vesicle-lysis profile make it useful for localization, but not as a standalone quantitative cholesterol assay.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-09-11
Dong and colleagues developed a tumor-microenvironment-responsive nanoparticle system for systemic delivery of PTEN mRNA in trastuzumab-resistant HER2-positive breast cancer models. The approach restored PTEN expression, inhibited persistently active PI3K/Akt signaling, and improved the antitumor effect of trastuzumab, while also illustrating the delivery barriers that must be addressed in therapeutic mRNA research.
-
Hexamethonium Bromide: Assay Reliability Guide
2026-09-11
This scenario-based guide explains how Hexamethonium Bromide, SKU B1592, can be used as a mechanistic perturbation tool in autonomic and neuronal signaling experiments without confusing receptor blockade with direct cytotoxicity. It covers assay compatibility, solution handling, interpretation of ganglionic blockade, and practical supplier-selection criteria.
-
Hexamethonium Bromide in Autonomic Research
2026-09-10
A translational framework for using Hexamethonium Bromide to separate autonomic ganglia contributions from vascular, hormonal, and reflex mechanisms in sex-aware hypertension and neuronal signaling studies.
-
Ruxolitinib Workflow for JAK1/2 Studies
2026-09-10
Build reproducible Ruxolitinib assays for pathway inhibition, progenitor-cell profiling, and high-dimensional tumor immunology. This workflow connects INCB018424 pharmacology with spectral flow cytometry while emphasizing solvent control, phospho-readouts, and careful interpretation of combination studies.
-
Sunitinib: From RTK Blockade to Ferroptosis
2026-09-09
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with established anti-angiogenic activity and emerging relevance to ferroptosis-centered renal cancer research. This guide translates recent TRIB3–SLC7A11/GPX4 findings into practical assay design and resistance-biology decisions.
-
Baicalin: Practical Workflows for Plasticity Research
2026-09-09
Baicalin enables a practical bridge between adult visual-cortex plasticity assays and pathway-focused cancer research. This guide translates the latest mouse findings into formulation, dosing, imaging, molecular-validation, and troubleshooting workflows while keeping evidence-supported claims separate from exploratory recommendations.